chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I63.9 ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY 12/16/2021 CEREBRAL EMBOLISM I63.9 ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY 12/16/2021 ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY I63.9 ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY 12/16/2021 ALTERED MENTAL STATUS, UNSPECIFIED
Patient received an expired dose of the Moderna COVID-19 vaccine/ The vial was punctured yesterday, 28DEC2021, and used for up to 17 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine/ The vial was punctured yesterday, 28DEC2021, and used for up to 17 hours post puncture) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine/ The vial was punctured yesterday, 28DEC2021, and used for up to 17 hours post puncture). On 29-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine/ The vial was punctured yesterday, 28DEC2021, and used for up to 17 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.
sick and could not get out of bed/ sick for about 1.5 weeks; had a lump the size of a golf ball on her arm; heart was also racing again (like when she had COVID19) and her pulse was very fast.; As if I had COVID19 all over again; pulse was very fast; arm was also painful; fever of 102.7 F; headache; throat was dry; As if she was losing her voice; This spontaneous case was reported by a consumer and describes the occurrence of DRY THROAT (throat was dry), ILLNESS (sick and could not get out of bed/ sick for about 1.5 weeks), AXILLARY MASS (had a lump the size of a golf ball on her arm), PALPITATIONS (heart was also racing again (like when she had COVID19) and her pulse was very fast.) and COVID-19 (As if I had COVID19 all over again) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Severe) in March 2020. Concurrent medical conditions included Asthma.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced DRY THROAT (throat was dry) and APHONIA (As if she was losing her voice). On 13-Jan-2021, the patient experienced ILLNESS (sick and could not get out of bed/ sick for about 1.5 weeks), AXILLARY MASS (had a lump the size of a golf ball on her arm), PALPITATIONS (heart was also racing again (like when she had COVID19) and her pulse was very fast.), COVID-19 (As if I had COVID19 all over again), HEART RATE INCREASED (pulse was very fast), PAIN IN EXTREMITY (arm was also painful), PYREXIA (fever of 102.7 F) and HEADACHE (headache). At the time of the report, DRY THROAT (throat was dry), ILLNESS (sick and could not get out of bed/ sick for about 1.5 weeks), PALPITATIONS (heart was also racing again (like when she had COVID19) and her pulse was very fast.), COVID-19 (As if I had COVID19 all over again), HEART RATE INCREASED (pulse was very fast), APHONIA (As if she was losing her voice), PAIN IN EXTREMITY (arm was also painful), PYREXIA (fever of 102.7 F) and HEADACHE (headache) outcome was unknown and AXILLARY MASS (had a lump the size of a golf ball on her arm) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, Body temperature: 102.7 f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment included Advil
Neuropathy in the feet; Hemochromatosis; 1st dose 21 jan, 2nd dose 26 feb; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (Neuropathy in the feet), HAEMOCHROMATOSIS (Hemochromatosis) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 21 jan, 2nd dose 26 feb) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 032L20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 21 jan, 2nd dose 26 feb). In March 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NEUROPATHY PERIPHERAL (Neuropathy in the feet) and HAEMOCHROMATOSIS (Hemochromatosis). The patient was treated with Manual therapy (Acupuncture using medicines) for Neuropathy peripheral and Manual therapy (Acupuncture using medicines) for Haemochromatosis. On 26-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 21 jan, 2nd dose 26 feb) had resolved. At the time of the report, NEUROPATHY PERIPHERAL (Neuropathy in the feet) and HAEMOCHROMATOSIS (Hemochromatosis) outcome was unknown.            It was reported that the patient started experiencing events 2 weeks post second dose of vaccine and was treated by a doctor of  medicine for a neuropathy in feet, patient reported that hemochromatosis is when there was excess iron in the feet.
Varicella, Varicella - Information has been received from a nurse practitioner concerning a 1 year old male who in approximately 1996 was vaccinated with one dose of varicella virus vaccine live.  Nine months after vaccination, the patient experienced a mild case of chickenpox with approximately 16 lesions.  At five years of age.  the patient experienced a full blown case of chickenpox, with approximately 20 lesions.  It was noted this was only second day of virus.  medical attention was sought.  There was no fever.  The patient was exposed to chickenpox in day care.
This case is a cluster of unidentified patients who experienced injuries when the phalange of the syringe broke for FLUZONE. Initial report was received from a health care professional on 23 February 2012. Unidentified patients (genders, ages and date of birth not reported) had experienced injuries after the phalange of FLUZONE (lot number not reported) syringes broke. No additional information was available at the time of the report. The patients' outcomes were not reported. Documents held by sender: None.
When I got up on the 8th I didn't feel good. I went to the bathroom and filled the toilet bowl with blood. I went to the emergency room. The doctor ran a urine test and there was no sign of infection. The doctor stated that it could possibly be a yeast infection but I had no signs of that. After she gave me some medicine I still didn't feel well. I felt run down and weak. On 4/22 I started feeling really bad. I had a high fever, chills, nausea, and vomiting. I went to urgent care they did a COVID test that came back negative, I was prescribed an inhaler, Z-PAK and a steroids. All they knew was there was something affecting my lungs.
Swelling/redness 15x15cm diffuse erythema good range of motion. Ice and MOTRIN -monitor.
She had severe pain at the injection site all 3 times, but she has also started growing a lite covering of hair on her back since these injections!
Information has been received from a nurse practitioner concerning an 18 year old female who in October 2007, was administered her third dose of vaccination with GARDASIL, 0.5ml, IM. "About one month later" the patient experienced chronic head aches. Subsequently the patient was treated with NEURONTIN and Ibuprofen. The patient's chronic head aches persisted. The patient sought medical at the nurse practitioner's office. Additional information has been requested.
pt recvd vax;6pm began v,had d;episodes of dizziness & felt very lethargic;pt remained in bed all day 20oct94; very tired; on 21oct pt felt better;
Information has been received from a licensed practical nurse, for GARDASIL, a Pregnancy Registry product, concerning a newborn female whose mother was pregnant at 19 years old and was with low iron, nausea, penicillin allergy, UTI (Urinary tract infection), vomiting. On 17-JUL-2012, the mother was vaccinated intramuscular with 0.5 dose of GARDASIL (lot # 672233/1561AA, exp. date 26-AUG-2014). The mother became pregnant with LMP (Last Menstrual Period) of 25-MAY-2012 and EDD (estimated date of delivery) was 01-MAR-2013 (also reported as 17-FEB-2013). On 20-FEB-2013 at 40 weeks 3 days gestation, the mother spontaneous delivered the infant via vaginal. The infant was weighing 7 lbs 7 oz, with Length of 20 inches, Head circumference of 13 inches. The infant experienced no complications during the delivery. The infant had congenital anomalies (unspecified). It also reported that the infant was normal. Apgar score was 7 at one minute and 9 at 5 minute. At the time of report, the outcome of event was unknown. The mother's experience was captured in MARRS#11207USA006880. Additional information has been requested.
Awakened drenched in sweat and muscles useless. EMTs got me to an emergency room. Battery of scans and tests eliminated usual suspects. Muscle use returned by midafternoon.
Possible allergic reaction: dizziness and nausea, then difficulty breathing with wheezing and chest tightness. No hives or edema, 911 called, gave Albuterol tx.
Tongue swelled and then went numb - like novacaine had been shot into it, throat swelling by 6 PM, took a big swig of Benadryl, went to Fire station, transported by ambulance to ER, blood pressure got way too low on ambulance ride, difficulty breathing/taking air in, IV applied - hospital by 6:30 PM, breathing still difficult, blood pressure better until it dropped again, IV given and monitored. Stable and discharged around midnight. Friday - Tuesday - very tired, heavy arms and legs, sore throat and tongue, limited to soft, bland. foods.
Left arm. Large, red, swollen, hot , indurated and itchy rxn almost 1/2 of left upper arm.
Information has been received from a 27 year old female with a history of papilloma viral infection and loop electrosurgical excision procedure in January 2007, who was vaccinated with Gardasil. Concomitant therapy included ALLEGRA and YAZ. Subsequently, the patient received two doses of the vaccine. After the first vaccination she experienced pain that the injection site (right arm) which hurt and burn. She did not experience any injection site reactions after the second injection (left arm). She experienced headache approximately one day after her first and second injections. About a week after the second injection, she developed genital warts on her outer lip. She reported that she is not sexually active. At the time of this report, the genital warts persisted. Her last dose is due on 17-MAY-2007. Additional information has been requested.
CHEST PAIN, HIGH HEART RATE, HIGH BLOOD PRESSURE 3 WEEKS AFTER THE SHOT. SAID THE DOCTOR DIDN'T KNOW IF IT WAS RELATED
Chills, body aches, joint pain, back pain, tooth pain, lost sense of taste, headache
Vomiting 5 hrs after administration (from 5pm-12am), lethargic, fever (103 deg. F.). Three days later developed stye. Seven days later developed rash (lasted 3 days), three bloody noses in 2 weeks and four weeks of diarrhea.
soreness at the injection site / pain; little swelling at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, couple of hours after receiving Shingrix, the patient experienced injection site pain and injection site swelling. On an unknown date, the outcome of the injection site pain and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the injection site pain and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in right arm and experienced soreness at the injection site a couple of hours after the injection. The patient also had a little swelling at the injection site that lasted a couple of days before the pain and swelling resolved. The reporter consented to follow up. For tolerances of 2nd dose, refer case US2020187068, reported by same reporter for the same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020187068:same reporter
Patient developed myalgia, fever, and chills as well as achiness to the left arm after vaccination. These symptoms resolved within 24 hours after vaccination. On the 3rd day after vaccination, the patient developed vague, sharp, stabbing pain in the back of the head with radiation to the right temporal region.
Following Dose 2 in April  2021, I had muscle leg cramps for about 3 months and intense hot flashes (no fever), feeling like I am burning up inside my body.  These subsided in Oct 2021.  I felt good for two months, then I got my Booster on 12/3/2021 and that night, my body was on fire again and the muscle cramping has returned.  I am still experiencing intense fire inside my body (stronger than a menopause hot flash) and leg cramps.  I am convinced these are related to the vaccine since they started after Dose 2, died out about 6 months later, and have returned intensively again following my Booster.
Patient reported vertigo symptoms (dizziness, nausea, falling upon standing) starting on 5/8. She said she stood up and felt very dizzy, and ultimately ended up falling (did not specify if she fainted or fell due to feeling unbalanced). Since that time, she has continued to experience persistent nausea and dizziness.
had a sore arm for 3 days; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a 70-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than 6 months after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient itself. The age at vaccination was not reported. The patient received 1st dose of Shingles and had a sore arm for 3 days, that was it. The patient was happy that it was a lifetime vaccine and stated no problems at all. The follow up would not possible as no contact details were available. For tolerance of 2nd dose, refer case US2021AMR103067, by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR103067:same reporter, same patient, same vaccine, different dose (2nd dose)
Approxamately 18 hours after the shot, I experienced fatigue and  lethargy. After taking a short nap, late in the afternoon, a fever set in. Ultimately, it reached a maximum level of 103.6  in the evening.  After taking Extra Strength Tylenol every  2 hours, the temperature came down until it was normal the following day mid afternoon.
This spontaneous report as received from a health professional refers to a 12-month-old patient (gender was not reported). There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 11-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Red mark/bruise on arm since vaccine, quarter size in diameter muscle deterioration/hole under skin,1/4-1/2" deep
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information not provided.  Treatment information not provided.
Redness and swelling at injection site, warm to touch covers large area of back of arm.
Frequent loose Bowel Movements throughout day, chills, sore throat, malaise, slight nausea.
Burning mouth began 5 days post-vaccine (2) along with numbness/tingling in lower limbs that is not yet resolved.
4/18 Developed tenderness streaky at site red striae from site to antaxillary area no LA, started on Tequin 400mg one orally gel # 5.
This is a 27y.o. male without a significant past medical history who presents to with a chief complaint of hypoxia at rest. Pt notes increasing fatigue, generalized myalgias, productive cough w/ intermittently clear / green sputum, subjective fevers, and rhinorrhea/nasal congestion that onset 11/27. He was noted to be COVID positive outpatient. Patient's wife is an RN in the ED and took his pulse ox which demonstrated O2 sats in the 80s while at rest, prompting further evaluation in the ED. Associated symptoms include chest heaviness that has since resolved, tachycardia w/ rate up to 130s, dyspnea at rest that is not significantly exacerbated w/ ambulation, occasional wheeze, and diaphoresis w/ warmth sensation, however did not take his temperature outpatient. No sick contacts. No recent travel although was at a wedding recently, denies extended periods of lack of ambulation, flights nor car rides. No cigarette use / significant tobacco use. He has received 1 of 2 doses of the COVID vaccine. Upon arrival to the ED: Vitals: T 98.6°F, BP 128/80, HR 117, RR 22, SpO2 95% on room air, although noted to drop O2 sats to the 80s. Lab work obtained and remarkable for: CBC unremarkable. BMP unremarkable Imaging demonstrates: CXR: no acute cardiopulmonary process. Patient placed on supplemental O2, started on decadron. Infectious Disease has been consulted.
Rash on his shoulder, about 3 inches, inconsistent shape, not just round and not consistent in color (some areas darker and some areas lighter). It was about 60 percent dissipated now; Pain in the shoulder at the shot area; Some discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Some discomfort), RASH (Rash on his shoulder, about 3 inches, inconsistent shape, not just round and not consistent in color (some areas darker and some areas lighter). It was about 60 percent dissipated now) and INJECTION SITE PAIN (Pain in the shoulder at the shot area) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02SB21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Aug-2021, the patient experienced DISCOMFORT (Some discomfort) and INJECTION SITE PAIN (Pain in the shoulder at the shot area). On 15-Aug-2021, the patient experienced RASH (Rash on his shoulder, about 3 inches, inconsistent shape, not just round and not consistent in color (some areas darker and some areas lighter). It was about 60 percent dissipated now). On 09-Aug-2021, DISCOMFORT (Some discomfort) and INJECTION SITE PAIN (Pain in the shoulder at the shot area) had resolved. At the time of the report, RASH (Rash on his shoulder, about 3 inches, inconsistent shape, not just round and not consistent in color (some areas darker and some areas lighter). It was about 60 percent dissipated now) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided by the reporter.
Patient states broke out in a rash on 04/01/2019 on her face and arms, and the next day it spread to her legs and torso. Patient was advised to stay away from unvaccinated individuals, and pregnant woman. Patient was advised to seek a health care provider if new symptoms appeared.  On 04/05/2019 Patient states her rash is getting better mostly on her face and arms. Patient denied any other new symptoms at this time.
Pt was given a 12+ Pfizer Bivalent dose instead of a 5-11 Pfizer Bivalent dose
Patient described onset of symptoms about 12 hours after administration localized pruritus, pain, followed by general malaise and insomnia. Malaise with no pyrexia lasted about 24-36 hours but redness near injection site remains as of the time of reporting. This was in contrast to the first dose where patient reported no adverse affects except for minor discomfort at injection site.
got my Pfizer COVID vaccine March 30th 2021 @ 9am.  39 hours after my 1st Pfizer COVID vaccine, I woke up at 1 am from bed on April 1. I dry heaved and threw up from 1-5 am. Horrible headache, knees and ankles weak and sore, no appetite, chills, cold sweats, nausea,   April 1, 6 am-5 pm I napped with chills and cold sweats.
COVID 19 treatment; COVID 19 treatment; Dose 4: Pfizer/BioNTech / Dose 3: Moderna / Dose 1 and 2: Manufacturer unknown; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Sep2022 as dose 4 (booster), single (Lot number: GH9693) at the age of 68 years, in right arm for COVID-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 29Dec2021 as dose 3 (booster), single (Lot number: 032h21a), in left arm for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "Chronic lymphocytic leukemia" (unspecified if ongoing). There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 27Sep2022, outcome "unknown", described as "Dose 4: Pfizer/BioNTech / Dose 3: Moderna / Dose 1 and 2: Manufacturer unknown"; DRUG INEFFECTIVE (medically significant), 1 year 2 months 18 days after the suspect product(s) administration, outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Mar2023) Negative; (19Mar2023) Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 09Mar2023 to 14Mar2023.
The same evening that the patient recieved the vaccine she felt muscle aches all over, lethargy, fever, rash at the injection site